← Browse by Condition
Medical Condition

infectious disease

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1

ClinicalMetric tracks all active clinical trials for infectious disease sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — infectious disease Clinical Trials

How many clinical trials are currently recruiting for infectious disease?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for infectious disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for infectious disease?
infectious disease research spans Phase 1 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a infectious disease clinical trial?
Eligibility criteria for infectious disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Top Sponsors
Barcelona Institute for Global Health 1 trial
Brooklyn Clinical Research 1 trial
Institut National de la Santé Et de la Recherche Médicale, France 1 trial
University of Minnesota 1 trial

Recruiting Clinical Trials

NCT06422338
Recruiting
A Rapid Triage Test to Improve Risk-stratification of Febrile Children (EChiLiBRiST, Clinical Trial 1, Outpatients)
Enrollment
5,212 pts
Location
Gabon, Mozambique
Sponsor
Barcelona Institute for Global...
View Trial →
NCT06492187
Recruiting
Triage Survey for Infectious Disease Eligibility
Enrollment
10,000 pts
Location
United States
Sponsor
Brooklyn Clinical Research
View Trial →
NCT06024421 Phase 1
Recruiting
Evaluation of Tolerance and Pharmacokinetic Profile of High Doses of Favipiravir in Healthy Volunteers
Enrollment
39 pts
Location
France
Sponsor
Institut National de la Santé ...
View Trial →
NCT07069400
Recruiting
An International Observational Study of Adults With Acute Infection
Enrollment
1,500 pts
Location
United States, Argen...
Sponsor
University of Minnesota
View Trial →

Related Conditions

febrile illness (1) child only (1) vaccination infection (1) hiv 1 infection (1) pharmacology (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology